Company Performance Metrics
ninety3 Biotech develops botanical pharmaceutical drugs focused on critical unmet needs in women’s health. The company concentrates on sleep disturbances associated with menopause, a condition affecting a large share of peri- and postmenopausal women. It focuses on non-hormonal therapies, moving away from traditional hormone replacement treatments.
Its research and development programs center on highly optimized plant-extract drug candidates that are intended to be licensed pharmaceutical products. ninety3 Biotech builds its work on multidisciplinary expertise in botanical medicine, clinical research, neuroscience, sleep science, and female healthcare. The company emphasizes robust clinical research models to discover and evaluate botanical candidates for menopause-related sleep disorders.